Effects of Clinical Pilates Exercises on Glycemic Control, Blood Lipids and Physical Fitness Parameters in Prediabetes
1 other identifier
interventional
42
1 country
1
Brief Summary
To examine the effects of clinical pilates exercise on glycemic control, blood lipids and physical fitness parameters in prediabetics. Subjects will be divided into two groups through randomization.Subjects in the 1st group will be included in the control group and will continue their routine. Subjects in the 2nd group will be given clinical pilates exercise training. All subjects will be evaluated at the start of treatment, and week 16.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2024
CompletedFirst Submitted
Initial submission to the registry
May 16, 2024
CompletedFirst Posted
Study publicly available on registry
June 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2025
CompletedApril 23, 2025
April 1, 2025
4 months
May 16, 2024
April 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The glycosylated hemoglobin A1c
An A1C test result reflects your average blood sugar level for the past two to three months. Specifically, the A1C test measures what percentage of hemoglobin proteins in your blood are coated with sugar (glycated). Hemoglobin proteins in red blood cells transport oxygen. The higher your A1C level is, the poorer your blood sugar control and the higher your risk of diabetes complications.
at baseline and at the end of the 16th week
Secondary Outcomes (20)
Fasting Blood Glucose
at baseline and at the end of the 16th week
Fasting insulin
at baseline and at the end of the 16th week
HOMA-IR
at baseline and at the end of the 16th week
HDL, LDL
at baseline and at the end of the 16th week
Vitamin D
at baseline and at the end of the 16th week
- +15 more secondary outcomes
Study Arms (2)
Control Group
NO INTERVENTIONDiabetes education will be given at the beginning and ways to prevent type 2 diabetes will be explained.Evaluation will be made at the beginning and at the end of 16 weeks.
Exercise Group
EXPERIMENTALDiabetes education will be given at the beginning and ways to prevent type 2 diabetes will be explained.Clinical pilates exercises will be performed.It will consist of a warm-up, main exercise and a cool-down period.Exercises will start with 10 repetitions and will be gradually increased in 3-week periods.Before the exercise training begins, all participants will be informed about clinical pilates and its basic principles will be explained. In the first session; The 5 key elements of pilates that should not be disrupted during exercises are; breathing, centering, rib cage placement, shoulder placement, head and neck placement will be taught. Exercise program will be done 3 days a week for 16 weeks.
Interventions
A 16-week clinical pilates exercise program will be applied 3 days a week for 60 minutes each session. It will consist of a warm-up, main exercise and a cool-down period.Exercises will start with 10 repetitions and will be gradually increased in 3-week periods.
Eligibility Criteria
You may qualify if:
- Being diagnosed with Prediabetes
- Being between the ages of 30-60
- Not having received physiotherapy in the last 6 months
- Being physically inactive (\<150 min/week or \<600 MET/week according to the International Physical Activity Survey Short Version)
You may not qualify if:
- Having a history of type 2 diabetes
- Taking any supplements to maintain weight control
- Having a history of acute trauma affecting the movement system within the last month
- Presence of orthopedic/neurological/cardiopulmonary disease affecting the movement system
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eastern Mediterranean University
Mersin, Famagusta, 99450, Turkey (Türkiye)
Related Publications (2)
ADA(Am.DiabetesAssoc.).2020.2.Classificationanddiagnosisofdiabetes:StandardsofMedicalCare in Diabetes-2020. Diabetes Care 43(Suppl. 1):S14-31
BACKGROUNDEchouffo-Tcheugui JB, Selvin E. Prediabetes and What It Means: The Epidemiological Evidence. Annu Rev Public Health. 2021 Apr 1;42:59-77. doi: 10.1146/annurev-publhealth-090419-102644. Epub 2021 Dec 23.
PMID: 33355476BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ayşen Karaman, MSc
EMU
- STUDY DIRECTOR
Ender Angın, PhD
EMU
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 16, 2024
First Posted
June 11, 2024
Study Start
May 15, 2024
Primary Completion
September 15, 2024
Study Completion
March 15, 2025
Last Updated
April 23, 2025
Record last verified: 2025-04